A case of Budd-Chiari Syndrome presenting in a lady with newly diagnosed Churg-Strauss Syndrome [5]

Rheumatology

Volumn 46, Issue 5, 2007, Pages 890-

  Campbell, Claire D ^a   Marshall, D A S ^a  

^a INVERCLYDE ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN; PREDNISOLONE; WARFARIN;

ADULT; ASCITES; ASTHMA; BUDD CHIARI SYNDROME; CASE REPORT; CHURG STRAUSS SYNDROME; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; LETTER; LEUKOCYTOCLASTIC VASCULITIS; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER VEIN THROMBOSIS; MACULOPAPULAR RASH; PARACENTESIS; PRIORITY JOURNAL; SKIN BIOPSY; THROMBOCYTOPENIA; THROMBOSIS; EOSINOPHIL; LEUKOCYTE COUNT; PATHOLOGY;

ADULT; CHURG-STRAUSS SYNDROME; EOSINOPHILS; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LEUKOCYTE COUNT;

EID: 34347217130     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem027     Document Type: Letter

References (6)

1. Elouaer-Blanc L, Zafrani ES, Farcet JP, Giarardin M-F S-M, Mathieu D, Dhumeaux D. Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. Arch Intern Med 1985;145:751-3.
2. Ames PRJ, Roes L, Lupoli S et al. Thrombosis in Churg-Strauss Syndrome. Beyond vasculitis? Br J Rheumatol 1996;35:1181-3.
3. Garcia G, Achouh L, Cobarzan D, Fichet D, Humbert M. Severe thromboembolic disease in Churg-Strauss syndrome, Allergy 2005;60:409-10.
4. Young ID, Clark RN, Manley PN, Groll A, Simon JB. Response to steroids in Budd-Chìari Syndrome caused by idiopathic granulomatous venultis. Gastroenterology 1988;94:503-7.
5. Maukai HY, Ninomiya H, Ohtani K, Nagasawa T, Abe T. Major basic protein binding to thrombomodulin potentially contributes to thrombosis in patients with eosinophilia. Br J Haematol 1995;90:892-9.
6. Wang JG, Mahmud SA, Thompson JA, Geng JG, Kkey NS, Slungaard A. The principal eosinophil peroxidise product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: A potential mechanism for thrombosis in eosinophilic inflammatory states. Blood 2006;107:558-65.